• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

深度测序揭示三阴性乳腺癌中的微小RNA表达特征

Deep Sequencing Reveals a MicroRNA Expression Signature in Triple-Negative Breast Cancer.

作者信息

Chang Yao-Yin, Lai Liang-Chuan, Tsai Mong-Hsun, Chuang Eric Y

机构信息

Department of Electrical Engineering, Graduate Institute of Biomedical Electronics and Bioinformatics, National Taiwan University, No 1 Sec 4 Roosevelt Road, Taipei, Taiwan.

Bioinformatics and Biostatistics Core, NTU Center of Genomic Medicine, Taipei, Taiwan.

出版信息

Methods Mol Biol. 2018;1699:99-111. doi: 10.1007/978-1-4939-7435-1_8.

DOI:10.1007/978-1-4939-7435-1_8
PMID:29086372
Abstract

Deep sequencing is an advanced technology in genomic biology to detect the precise order of nucleotides in a strand of DNA/RNA molecule. The analysis of deep sequencing data also requires sophisticated knowledge in both computational software and bioinformatics. In this chapter, the procedures of deep sequencing analysis of microRNA (miRNA) transcriptome in triple-negative breast cancer and adjacent normal tissue are described in detail. As miRNAs are critical regulators of gene expression and many of them were previously reported to be associated with the malignant progression of human cancer, the analytical method that accurately identifies deregulated miRNAs in a specific type of cancer is thus important for the understanding of its tumor behavior. We obtained raw sequence reads of miRNA expression from 24 triple-negative breast cancers and 14 adjacent normal tissues using deep sequencing technology in this work. Expression data of miRNA reads were normalized with the quantile-quantile scaling method and were analyzed statistically. A miRNA expression signature composed of 25 differentially expressed miRNAs showed to be an effective classifier between triple-negative breast cancers and adjacent normal tissues in a hierarchical clustering analysis.

摘要

深度测序是基因组生物学中的一项先进技术,用于检测DNA/RNA分子链中核苷酸的精确顺序。深度测序数据分析还需要在计算软件和生物信息学方面具备专业知识。在本章中,将详细描述三阴性乳腺癌及癌旁正常组织中微小RNA(miRNA)转录组的深度测序分析过程。由于miRNA是基因表达的关键调节因子,且先前有许多报道称它们与人类癌症的恶性进展相关,因此准确识别特定类型癌症中失调miRNA的分析方法对于理解其肿瘤行为至关重要。在本研究中,我们使用深度测序技术获得了24例三阴性乳腺癌及14例癌旁正常组织的miRNA表达原始序列读数。miRNA读数的表达数据采用分位数-分位数缩放法进行标准化,并进行统计学分析。在层次聚类分析中,由25个差异表达miRNA组成的miRNA表达特征显示为三阴性乳腺癌与癌旁正常组织之间的有效分类器。

相似文献

1
Deep Sequencing Reveals a MicroRNA Expression Signature in Triple-Negative Breast Cancer.深度测序揭示三阴性乳腺癌中的微小RNA表达特征
Methods Mol Biol. 2018;1699:99-111. doi: 10.1007/978-1-4939-7435-1_8.
2
Deregulated microRNAs in triple-negative breast cancer revealed by deep sequencing.深度测序揭示三阴性乳腺癌中失调的微小RNA
Mol Cancer. 2015 Feb 10;14:36. doi: 10.1186/s12943-015-0301-9.
3
Deep sequencing reveals complex mechanisms of microRNA deregulation in colorectal cancer.深度测序揭示了结直肠癌中微小RNA失调的复杂机制。
Int J Oncol. 2014 Aug;45(2):603-10. doi: 10.3892/ijo.2014.2474. Epub 2014 May 29.
4
MicroRNA expression and gene regulation drive breast cancer progression and metastasis in PyMT mice.微小RNA表达与基因调控驱动PyMT小鼠乳腺癌的进展和转移。
Breast Cancer Res. 2016 Jul 22;18(1):75. doi: 10.1186/s13058-016-0735-z.
5
Identification and characterization of microRNAs expressed in human breast cancer chemo-resistant MCF-7/Adr cells by Solexa deep-sequencing technology.利用 Solexa 深度测序技术鉴定和分析人乳腺癌耐药 MCF-7/Adr 细胞中表达的 microRNAs。
Biomed Pharmacother. 2015 Oct;75:173-8. doi: 10.1016/j.biopha.2015.07.019. Epub 2015 Aug 17.
6
A serum microRNA signature predicts tumor relapse and survival in triple-negative breast cancer patients.血清 microRNA 特征可预测三阴性乳腺癌患者的肿瘤复发和生存。
Clin Cancer Res. 2015 Mar 1;21(5):1207-14. doi: 10.1158/1078-0432.CCR-14-2011. Epub 2014 Dec 29.
7
Differentially expressed microRNAs in exosomes of patients with breast cancer revealed by next‑generation sequencing.下一代测序揭示乳腺癌患者外泌体中差异表达的 microRNAs。
Oncol Rep. 2020 Jan;43(1):240-250. doi: 10.3892/or.2019.7401. Epub 2019 Nov 6.
8
Dual regulation by microRNA-200b-3p and microRNA-200b-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancer.微小RNA-200b-3p和微小RNA-200b-5p对三阴性乳腺癌上皮-间质转化抑制的双重调控
Oncotarget. 2015 Jun 30;6(18):16638-52. doi: 10.18632/oncotarget.3184.
9
Glucocorticoid receptor overexpression slightly shifts microRNA expression patterns in triple-negative breast cancer.糖皮质激素受体过表达略微改变三阴性乳腺癌中的 microRNA 表达模式。
Int J Oncol. 2018 Jun;52(6):1765-1776. doi: 10.3892/ijo.2018.4336. Epub 2018 Mar 27.
10
Signature miRNAs in colorectal cancers were revealed using a bias reduction small RNA deep sequencing protocol.采用一种减少偏差的小RNA深度测序方案揭示了结直肠癌中的特征性微小RNA。
Oncotarget. 2016 Jan 26;7(4):3857-72. doi: 10.18632/oncotarget.6460.

引用本文的文献

1
Three-microRNA expression signature predicts survival in triple-negative breast cancer.三种微小RNA表达特征可预测三阴性乳腺癌的生存率。
Oncol Lett. 2020 Jan;19(1):301-308. doi: 10.3892/ol.2019.11118. Epub 2019 Nov 19.
2
Triple Negative Breast Cancer Profile, from Gene to microRNA, in Relation to Ethnicity.三阴性乳腺癌概况:从基因到微小RNA,与种族的关系
Cancers (Basel). 2019 Mar 13;11(3):363. doi: 10.3390/cancers11030363.